Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Change In Payables And Accrued Expense?

Wanbangde Pharmaceutical Holding Group Co's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Wanbangde Pharmaceutical Holding Group Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Wanbangde Pharmaceutical Holding Group Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was ¥0 Mil. It means Wanbangde Pharmaceutical Holding Group Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Wanbangde Pharmaceutical Holding Group Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Change In Payables And Accrued Expense Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Wanbangde Pharmaceutical Holding Group Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Wanbangde Pharmaceutical Holding Group Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Wanbangde Pharmaceutical Holding Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Change In Payables And Accrued Expense

Traded in Other Exchanges

N/A

Address

Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008

Website

http://www.wepon.com.cn

Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.

Executives

Zhao Shou Ming	Directors, executives
Wang Tian Fang	Director
Li Rong Fang	Supervisors
Zhu Jian Xin	Directors, executives
Yang Jin Rong	Executives
Song Tie He	Directors, executives
Song Jian Hua	Executives
Pan Yun Chu	Director
Yu Ju Ming	Executives
Yang Mei Gen	Executives
Tao Jian Feng	Supervisors
Qian Shu Sheng	Executives
Shen Bai Ming	Director
Xu Yin Sheng	Director
Shuang Zhi Wei	Executives

Wanbangde Pharmaceutical Holding Group Co Headlines

No Headlines